A Phase II Study of Docetaxel and Carboplatin as Neoadjuvant Therapy for Patients with Early T and Advanced N Stage Nasopharyngeal Carcinoma(NPC)

Reviewer: Tracy d'Entremont, MD
OncoLink
Ultima Vez Modificado: 31 de mayo del 2003

Translation for this article does not exist

Frequently Asked Questions